Development of a patient-reported outcome measure of tophus burden: The Tophus Impact Questionnaire (TIQ-20)

Annals of the Rheumatic Diseases

Volumn 74, Issue 12, 2015, Pages 2144-2150

  Aati, Opetaia ^a   Taylor, William J ^b   Siegert, Richard J ^c   Horne, Anne ^a   House, Meaghan E ^a   Tan, Paul ^a   Drake, Jill ^d   Stamp, Lisa K ^d   Dalbeth, Nicola ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

URATE; URIC ACID;

20 ITEM TOPHUS IMPACT QUESTIONNAIRE; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONSTRUCT VALIDITY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE EXACERBATION; DUAL ENERGY COMPUTED TOMOGRAPHY; FEMALE; GOUT; GRIP STRENGTH; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RASCH ANALYSIS; REPRODUCIBILITY; URIC ACID BLOOD LEVEL; BLOOD; MIDDLE AGED; OUTCOME ASSESSMENT; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GOUT; HUMANS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; URIC ACID;

EID: 84954285577     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205671     Document Type: Article

References (35)

1. Dalbeth N, Pool B, Gamble GD, et al. Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010;62:1549-56.
2. Hench PS. The diagnosis of gout and gout arthritis. J Lab Clin Med 1936;22:48-55.
3. Dalbeth N, House ME, Horne A, et al. Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout. BMC Musculoskelet Disord 2013;14:363.
4. Becker MA, Schumacher HR, Benjamin KL, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009;36:1041-8.
5. Dalbeth N, Clark B, Gregory K, et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis 2009;68:1290-5.
6. Perez-Ruiz F, Martinez-Indart L, Carmona L, et al. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 2014;73:177-82.
7. Dalbeth N, Schauer C, Macdonald P, et al. Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis 2011;70:597-604.
8. Singh JA, Taylor WJ, Simon LS, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 2011;38:1452-7.
9. Grainger R, Taylor WJ, Dalbeth N, et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009;36:2346-55.
10. Dalbeth N, McQueen FM, Singh JA, et al. Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities. J Rheumatol 2011;38:1458-61.
11. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
12. DeWalt DA, Rothrock N, Yount S, et al. Evaluation of item candidates: the PROMIS qualitative item review. Med Care 2007;45:S12-21.
13. Aati O, Taylor WJ, Horne A, et al. Towards development of a Tophus Impact Questionnaire: a qualitative study exploring the experience of people with tophaceous gout. J Clin Rheumatol 2014;20:251-55.
14. Wolfe F, Michaud K, Pincus T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 2004;50:3296-305.
15. Dalbeth N, Collis J, Gregory K, et al. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford) 2007;46:1804-7.
16. Rajan A, Aati O, Kalluru R, et al. Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal study. Arthritis Res Ther 2013;15:R160.
17. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 2007;57:1358-62.
18. Smith EV. Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals. J Appl Meas 2002;3:205-31.
19. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
20. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician 1983;32:307-17.
21. Colwell HH, Hunt BJ, Pasta DJ, et al. Gout Assessment Questionnaire: Initial results of reliability, validity and responsiveness. Int J Clin Pract 2006;60:1210-17.
22. Taylor WJ. Gout measures: Gout Assessment Questionnaire (GAQ, GAQ2.0), and physical measurement of tophi. Arthritis Care Res (Hoboken) 2011;63(Suppl 11): S59-63.
23. Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-61.
24. Schumacher HR Jr, Becker MA, Palo WA, et al. Tophaceous gout: quantitative evaluation by direct physical measurement. J Rheumatol 2005;32:2368-72.
25. Perez-Ruiz F, Calabozo M, Pijoan JI, et al. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47:356-60.
26. Sundy JS, Baraf HS, Yood RA, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 2011;306:711-20.
27. Perez-Ruiz F, Martin I, Canteli B. Ultrasonographic measurement of tophi as an outcome measure for chronic gout. J Rheumatol 2007;34:1888-93.
28. Schumacher HR Jr, Becker MA, Edwards NL, et al. Magnetic resonance imaging in the quantitative assessment of gouty tophi. J Clin Pract 2006; 60:408-14.
29. Dalbeth N, Clark B, Gregory K, et al. Computed tomography measurement of tophus volume: comparison with physical measurement. Arthritis Rheum 2007;57:461-5.
30. Choi HK, Al-Arfaj AM, Eftekhari A, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis 2009;68:1609-12.
31. Singh JA. The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout. Arthritis Res Ther 2014;16:R132.
32. Dalbeth N, House ME, Horne A, et al. The experience and impact of gout in Maori and Pacific people: a prospective observational study. Clin Rheumatol 2013;32:247-51.
33. Winnard D, Wright C, Taylor WJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 2012;51:901-9.
34. Boers M, Brooks P, Strand CV, et al. The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol 1998;25:198-9.
35. Alvarez-Hernandez E, Pelaez-Ballestas I, Vazquez-Mellado J, et al. Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum 2008;59:665-9.